Patents Examined by Eric Winakur
-
Patent number: 10194939Abstract: A sensor embedding device according to the present disclosure is a sensor embedding device which embeds a sensor in a subject, the sensor having a sensing region in which to detect a state of the subject, including: a needle to be inserted in the subject, the needle having a hole; a sensor retainer to retain the sensor so that the sensor is ready to be embedded inside the subject in such a manner that the sensing region is oriented in a predetermined direction; and a movable section to move the sensor into the subject with a slide of the sensor retainer inside the hole.Type: GrantFiled: November 13, 2015Date of Patent: February 5, 2019Assignee: Panasonic Intellectual Property Management Co., Ltd.Inventors: Masaru Minamiguchi, Yasuaki Okumura, Tatsurou Kawamura, Takahiro Aoki, Masahiko Shioi
-
Patent number: 10194847Abstract: An embodiment of the present disclosure seeks to smooth a perfusion index measurement through use of a baseline perfusion index measurement and/or through the use of multiple PI calculations. The combination of the baseline perfusion index measurement reduces an error between a calculated measurement of PI and actual conditions.Type: GrantFiled: March 16, 2015Date of Patent: February 5, 2019Assignee: Masimo CorporationInventor: Ammar Al-Ali
-
Patent number: 10194871Abstract: A biosensor control module is integrated in a vehicle and includes a transceiver configured to communicate with a plurality of PPG circuits. The PPG circuits have different locations, including a control button of the vehicle, key fob or steering wheel. The biosensor control module receives first spectral data including PPG waveforms from a first PPG circuit at a first location. The biosensor control module also receives second spectral data including PPG waveforms from a second PPG circuit at a second location. The biosensor control module combines the PPG waveforms from the first spectral data and the second spectral data to obtain health information of a user.Type: GrantFiled: December 29, 2017Date of Patent: February 5, 2019Assignee: SANMINA CORPORATIONInventor: Robert Steven Newberry
-
Patent number: 10188325Abstract: New wearable systems for noninvasive glucose sensing include an ultrasound generator, an ultrasound detector and a feedback unit. Methods for noninvasive glucose sensing using a wearable device include measuring a thickness (geometrical and/or optical) of a target tissue or a time of flight of ultrasound or optical pulses in the target tissue and determining a glucose value from the thickness of the target tissue or the time of flight in the target tissue in accordance with a target tissue thickness (geometrical and/or optical) or time of flight versus glucose calibration curve.Type: GrantFiled: November 27, 2015Date of Patent: January 29, 2019Inventor: Rinat O. Esenaliev
-
Patent number: 10188330Abstract: A physiological monitoring system may receive a sensor signal from a physiological sensor. The system may determine a parameter based on the sensor signal, for example variability of a blood oxygen saturation value or the percent modulation of a light signal. The system may determine a light drive parameter limit based on one or more parameters. For example, the system may determine a light drive current limit. The frequency of changes in the limit may be regulated using a state machine and other techniques that include hysteresis. An extant light drive parameter may be updated or changed in accordance with the light drive parameter limit and a light drive signal may be generated based on the light drive parameter.Type: GrantFiled: February 4, 2015Date of Patent: January 29, 2019Assignee: Covidien LPInventors: Ron Kadlec, John Mackinnon, Greg Lund, Andy Lin
-
Patent number: 10188329Abstract: A handheld device includes a contact surface, an optical module, a processor, a display module, and a user operable switch. The optical module is disposed on the contact surface. The optical module has at least one optical emitter and at least one optical detector. The at least one optical detector has a light shield associated with the contact surface. The light shield is configured to exclude ambient light from the contact surface when the contact surface abuts tissue of a patient. The processor is coupled to the optical module and configured to execute instructions for determining a measure of oximetry corresponding to the tissue. The display module is coupled to the processor and is configured to indicate the measure of oximetry. The user operable switch is configured to activate at least one of the processor, the optical module, and the display module.Type: GrantFiled: March 14, 2013Date of Patent: January 29, 2019Assignee: Nonin Medical, Inc.Inventors: Philip O. Isaacson, Timothy L. Johnson, Matthew Prior
-
Patent number: 10188328Abstract: The non-invasive biolipid concentration meter comprises: an irradiator (2) that emits light at a given intensity toward the inside of a living body from outside; a light intensity detector (3) that is disposed at a given distance from a position (21) irradiated with the light from the irradiator (2) and that determines the intensity of light emitted from the living body; a scattering coefficient calculator (4) that calculates the coefficient of light scattering within the living body on the basis of the light intensity determined with the light intensity detector (3); and a lipid concentration calculator (5) that calculates the lipid concentration in the living body on the basis of the coefficient of light scattering.Type: GrantFiled: November 14, 2013Date of Patent: January 29, 2019Assignees: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, MEDICAL PHOTONICS CO., LTD.Inventors: Koichi Shimizu, Kazuya Iinaga
-
Patent number: 10182749Abstract: A health care apparatus and an operating method thereof are provided. The method includes generating a first blood glucose pattern of an examinee that indicates a blood glucose level of the examinee over a first period of time, generating a second blood glucose pattern of the examinee that indicates the blood glucose level of the examinee over a second period of time, generating a third blood glucose pattern of the examinee that indicates the blood glucose level of the examinee over a third period of time, and calculating a glycemic index of the examinee based on the first blood glucose pattern, the second blood glucose pattern, and the third blood glucose pattern.Type: GrantFiled: August 25, 2015Date of Patent: January 22, 2019Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Jinyoung Park, Eunsung Park, Seongho Cho
-
Patent number: 10182764Abstract: According to embodiments, a system for processing a physiological signals is disclosed. The system may comprise a sensor for generating the physiological signal. The system may comprise a processor configured to receive and process the physiological signal in order to improve interpretation and subsequent analysis of the physiological signal. The processor may be configured to generate a wavelet transform based on the physiological signal. The processor may be configured to determine phase values corresponding to the subject's respiration based on the wavelet transform. The processor may be configured to generate a sinusoidal waveform that is representative of the subject's breathing based on the phase values. The system may also comprise a display device configured to display the sinusoidal waveform.Type: GrantFiled: June 24, 2015Date of Patent: January 22, 2019Assignee: NELLCOR PURITAN BENNETT IRELANDInventors: Paul Stanley Addison, James Nicholas Watson
-
Patent number: 10165969Abstract: A method that includes receiving first and second detection signals and electrocardiograph signals; wherein the first detection signals result from an illumination, by an oxygen saturation sensor included in a device that may be removably attached to a user, of a sternal angle of a user by infrared pulses; wherein the second detection signals result from an illumination, by the oxygen saturation sensor, of the sternal angle of a user by visible light pulses; wherein the electrocardiograph signals may be detected by an electrocardiography sensor that may be included in the device; generating a first waveform template that may be responsive to the first detection signals; generating a second waveform template that may be responsive to the second detection signals; calculating an indication of the oxygen saturation characteristic of the user in response to the first and second detection signals; detecting cardiac cycle durations that may be based upon the first and second detection signals; detecting electrocardType: GrantFiled: April 27, 2015Date of Patent: January 1, 2019Assignee: BRAEMAR MANUFACTURING, LLCInventors: Anna Levant, Zohar Brachia Halevi, Mordehay Amirim
-
Patent number: 10159412Abstract: The present disclosure includes a handheld processing device including medical applications for minimally and noninvasive glucose measurements. In an embodiment, the device creates a patient specific calibration using a measurement protocol of minimally invasive measurements and noninvasive measurements, eventually creating a patient specific noninvasive glucometer. Additionally, embodiments of the present disclosure provide for the processing device to execute medical applications and non-medical applications.Type: GrantFiled: May 4, 2015Date of Patent: December 25, 2018Assignee: Cercacor Laboratories, Inc.Inventors: Marcelo M. Lamego, Massi Joe E. Kiani, Jeroen Poeze, Cristiano Dalvi, Sean Merritt, Hung Vo, Gregory A. Olsen, Ferdyan Lesmana
-
Patent number: 10159434Abstract: Methods and systems disclosed herein may be operable to detect a presence or absence of an analyte in human tissue. An example method includes operating one or more light sources to illuminate a plurality of optodes with excitation light. Each optode is embedded in tissue at a respective location. The excitation light causes the optodes to emit emission light and the optodes are sensitive to at least one analyte such that the emission light emitted by the optodes is indicative of a presence or absence of at least one analyte in the tissue. An optical filter arrangement includes for each optode in the plurality of optodes a corresponding set of one or more optical filters. The method includes obtaining detector information from a detector arrangement optically coupled to the optical filter arrangement, and detecting the at least one analyte based on the detector information.Type: GrantFiled: November 30, 2015Date of Patent: December 25, 2018Assignee: Verily Life Sciences LLCInventors: Suresh Alla, John D Perreault, Victor Marcel Acosta, Seung Ah Lee
-
Patent number: 10156686Abstract: When monitoring blood oxygen levels in a patient during a magnetic resonance scan, detachable and reusable fiber optic cable heads (16, 18, 98, 131, 132) are coupled to an SpO2 monitor and to a hinged finger clip (40, 70, 90, 110, 190) on a patient. The finger clip (40, 70, 90, 110, 190) includes apertures (94, 196) and a retaining structure (44, 95, 198) to which a coupling portion of the fiber heads (16, 18, 98, 131, 132) are releasable attached. The retaining structure includes retaining clips (44, 198), slots (95), or the like that flexibly receive and align the fiber heads (16, 18, 98, 131, 132). The retaining structure (44, 95, 198) may be deformable, such that detachment of the fiber heads (16, 18, 98, 131, 132) at the end of the MR scan renders the finger clip (40, 70, 90, 110, 190) unusable to ensure that the clip is not reused, thereby preventing cross-infection between patients.Type: GrantFiled: May 4, 2010Date of Patent: December 18, 2018Assignee: KONINKLIJKE PHILIPS N.VInventor: Siegfried Kaestle
-
Patent number: 10149640Abstract: Disclosed herein are embodiments of methods and techniques for measuring oxygen levels of an implant. The implant can have a plurality of oxygen-sensitive microparticles incorporated throughout. The oxygen-sensitive microparticles can receive light and emit excitation light in response. The levels of excitation light emitted can be directly related to oxygen concentration in the implant.Type: GrantFiled: June 15, 2015Date of Patent: December 11, 2018Assignee: The Regents of the University of CaliforniaInventors: Elliot Botvinick, John Weidling
-
Patent number: 10149973Abstract: A multipart, non-uniform patient contact interface and method of use are disclosed.Type: GrantFiled: June 12, 2014Date of Patent: December 11, 2018Assignee: CARDIOTHRIVE, INC.Inventors: Douglas M. Raymond, Peter D. Gray, Walter T. Savage, Shelley J. Savage
-
Patent number: 10149639Abstract: A used photoacoustic apparatus includes: a light source capable of individually emitting light having a first wavelength at which absorption coefficients of oxyhemoglobin and deoxyhemoglobin are equal and light having a second wavelength; an acoustic detector that receives acoustic waves generated when the light having the first and second wavelengths is absorbed by an object; an absorption coefficient distribution generator that determines absorption coefficient distributions of an object interior; a blood vessel position determining unit that determines a blood vessel position from an absorption coefficient distribution corresponding to the first wavelength; an organism characteristics distribution calculator that determines an organism characteristics distribution from the absorption coefficient distributions; and a trimming unit that trims the organism characteristics distribution in accordance with the blood vessel position.Type: GrantFiled: March 29, 2012Date of Patent: December 11, 2018Assignee: CANON KABUSHIKI KAISHAInventors: Yoshiko Wada, Takuji Oishi
-
Patent number: 10143413Abstract: A device and method yielding a blood analysis employable in combination with an introducer for a catheter for a concurrent testing of blood from the introducer flash chamber during placement of a venous catheter. The device employs a colorimetric blood analysis to provide the user a visually discernable alert to the results of tested blood concurrent with the placement of the catheter with the introducer.Type: GrantFiled: October 16, 2014Date of Patent: December 4, 2018Assignee: KURIN, INC.Inventors: Chad Garrett, John W. Simpson
-
Patent number: 10136827Abstract: The invention features a vital sign monitor that includes: 1) a hardware control component featuring a microprocessor that operates as interactive, icon-driven GUI on an LCD; and, 2) a sensor component that connects to the control component through a shielded coaxial cable. The sensor features: 1) an optical component that generates a first signal; 2) a plurality electrical components (e.g. electrodes) that generate a second signal; and, 3) an acoustic component that generates a third signal. The microprocessor runs compiled computer code that operates: 1) the touch panel LCD; 2) a graphical user interface that includes multiple icons corresponding to different software operations; 3) a file-management system for storing and retrieving vital sign information; and 4) USB and short-range wireless systems for transferring data to and from the device to a PC.Type: GrantFiled: April 23, 2014Date of Patent: November 27, 2018Assignee: SOTERA WIRELESS, INC.Inventors: Matthew J. Banet, Marshal Singh Dhillon, Andrew Stanley Terry, Michael James Thompson, Zhou Zhou, Henk Visser, II, Adam Michael Fleming
-
Patent number: 10130296Abstract: An apparatus for noninvasively measuring a bio-analyte including a metering device configured to obtain at least one of light and electrical information representative of an amount of fibrous protein from skin of a subject; and a processor configured to determine information representative of an amount an analyte present in blood of the subject based on the obtained information representative of an amount of the fibrous protein.Type: GrantFiled: July 28, 2015Date of Patent: November 20, 2018Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Joonhyung Lee, Sangkyu Kim, Seongho Cho
-
Patent number: 10130291Abstract: The present invention relates to a method and system for estimating blood analyte levels using a noninvasive optical coherence tomography (OCT) based physiological monitor. An algorithm correlates OCT-based estimated blood analyte data with actual blood analyte data determined by other methods, such as invasively. OCT-based data is fit to the obtained blood analyte measurements to achieve the best correlation. Once the algorithm has generated sets of estimated blood analyte levels, it may refine the number of sets by applying one or more mathematical filters. The OCT-based physiological monitor can be calibrated using an Intensity Difference plot or the Pearson Product Moment Correlation method.Type: GrantFiled: May 25, 2017Date of Patent: November 20, 2018Assignee: MASIMO CORPORATIONInventors: Matthew J. Schurman, Walter J. Shakespeare, William Henry Bennett